JAK3 and psoriasis: In conclusion, previous studies have reported that oral astilbin could inhibit Th17 cell differentiation and ameliorate IMQ‐induced psoriasis‐like skin lesions by inhibiting the Jak3/Stat3 signalling pathway in BALB/c mice.13